| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| G873575 | 13190-34-6 | (R,S)-告依春, ≥98% Goitrin, ≥98% |
C5H7NOS | |
| R920676 | 1214672-15-7 | (Rac)-LM11A-31 dihydrochloride, 98% (Rac)-LM11A-31 dihydrochloride, 98% |
C12H25N3O2 | |
| R881678 | 1637542-34-7 | (Rac)-Nedisertib, 98% (Rac)-Nedisertib, 98% |
C24H21ClFN5O3 | |
| R884909 | 102120-99-0 | (Rac)-Rotigotine hydrochloride , ≥97% (Rac)-Rotigotine hydrochloride , ≥97% |
C19H26ClNOS | |
| R938363 | 153538-08-0 | (Rac)-ZD 9331, ≥98% (Rac)-Plevitrexed, ≥98% |
C26H25FN8O4 | |
| S872195 | 24140-30-5 | (s)-(+)-2-methylbutyl p-[(p-methoxybenzylidene)amino]cinnamate, 98% (s)-(+)-2-methylbutyl p-[(p-methoxybenzylidene)amino]cinnamate, 98% |
C22H25NO3 | |
| P872739 | 1675201-83-8 | (S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸, 99% PD-1/PD-L1 inhibitor 1, 99% |
C29H33NO5 | |
| P795989 | 1675201-83-8 | (S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸, 10mM in DMSO PD-1/PD-L1 inhibitor 1, 10mM in DMSO |
C29H33NO5 | |
| C884432 | 113665-84-2 | (S)-2-(2-氯苯基)-2-(6,7-二氢噻吩并[3,2-c]吡啶-5(4H)-基)乙酸甲酯, 98% (S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, 98% |
C16H16ClNO2S | |
| S887662 | 1695562-36-7 | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid, 98% (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid, 98% |
||
| M797675 | 1642288-47-8 | (S)-3-异丙基-6-((1-苯基乙基)氨基)嘧啶-2,4(1H,3H)-二酮, 10mM in DMSO (S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione, 10mM in DMSO |
C15H19N3O2 | |
| M881645 | 1642288-47-8 | (S)-3-异丙基-6-((1-苯基乙基)氨基)嘧啶-2,4(1H,3H)-二酮, ≥99% (S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione, ≥99% |
C15H19N3O2 | |
| S887672 | 2162982-11-6 | (S)-6-(4-氯苯基)-2-(3-氟苯基)-N-(1-羟基丙-2-基)-3-氧代-2,3-二氢哒嗪-4-甲酰胺, 98% (S)-6-(4-Chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, 98% |
C20H17ClFN3O3 | |
| S795543 | 2162982-11-6 | (S)-6-(4-氯苯基)-2-(3-氟苯基)-N-(1-羟基丙-2-基)-3-氧代-2,3-二氢哒嗪-4-甲酰胺, 10mM in DMSO (S)-6-(4-Chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, 10mM in DMSO |
C20H17ClFN3O3 | |
| S873182 | 1374356-45-2 | (S)-crizotinib, 99% (S)-crizotinib, 99% |
C21H22Cl2FN5O | |
| S881527 | 1699720-85-8 | (S)-ML753286 , ≥98% (S)-ML753286 , ≥98% |
C20H25N3O3 | |
| D873650 | 116539-59-4 | (S)-N-甲基-3-(萘-1-基氧)-3-(噻吩-2-基)丙烷-1-胺, 99% Duloxetine, 99% |
C18H19NOS | |
| D796004 | 116539-59-4 | (S)-N-甲基-3-(萘-1-基氧)-3-(噻吩-2-基)丙烷-1-胺, 10mM in DMSO Duloxetine, 10mM in DMSO |
C18H19NOS | |
| S881064 | 185517-74-2 | (S)-Rasagiline, ≥99% (S)-Rasagiline, ≥99% |
C12H13N | |
| S880706 | 202464-88-8 | (S)-Rasagiline mesylate, 98% (S)-Rasagiline mesylate, 98% |
C13H17NO3S |